Actively Recruiting
Salivary Biomarkers for Concussion
Led by Sys2Diag · Updated on 2026-03-16
80
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
Sponsors
S
Sys2Diag
Lead Sponsor
C
Centre National de la Recherche Scientifique, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
Concussion (CC) (also called mild head trauma), which accounts for 85% of all head injuries, is very common in professional and amateur athletes. CC is an injury to the brain resulting from the direct or indirect impact of external mechanical forces, momentarily disrupting its function on a cellular level. Unlike more serious head injury (moderate and severe), which can be diagnosed using neuroimaging techniques (CT, MRI, etc.), patients suffering from CC do not necessarily show visible signs of structural abnormalities. As a result, diagnosis of CC is offen difficult. Recently, several salivary biomarkers (proteins and nucleic acids) of sport related concussion have been identified in professional athletes. However, their reference values have not been determined with sufficient robustness to enable their employment in concussion diagnostic tests.
CONDITIONS
Official Title
Salivary Biomarkers for Concussion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male participants aged between 18 and 50 years old.
- Participants willing to comply with the study procedures.
- Participants capable of understanding the purpose, nature, and methodology of the study.
- Participants affiliated to a French social security system or beneficiaries of such a system.
- Participants who have signed the non-opposition form to participate in the research.
You will not qualify if you...
- Participants not affiliated to a French social security system or not beneficiaries of such a system.
- Participants deprived of liberty, protected adults, vulnerable individuals, or minors.
- Participants with a proven or suspected chronic infectious disease that may introduce a risk of contamination during sample handling.
- Participants who refuse to sign the non-opposition form to participate in the research.
- Participants who have had a recent stroke or epilepsy event within the past two months.
- Participants suffering from neurological diseases.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sys2Diag - Umr9005 Cnrs/Alcen
Montpellier, France, 34184
Actively Recruiting
Research Team
W
Wendpouiré A OUEDRAOGO, Msc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here